Patent Assignment
Reel/Frame 059242/0007
Assignment of Assignor's Interest
Recorded: 2022-03-11
Pages: 22
Assignor
AGEX THERAPEUTICS, INC.
Executed: 2022-03-04
Assignee
REVERSE BIOENGINEERING, INC.
1101 MARINA VILLAGE PARKWAY, SUITE 201, ALAMEDA, CALIFORNIA, 94501
Covered Properties
(21)
Improved Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
PCT:
PCT/US2017/036452 ↗
Methods for the Ex Vivo Induction of Tissue Regeneration in Microbiopsies
PCT:
PCT/US2022/012017 ↗
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
16/211,690 →
Publication:
US 2019/0175691
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,992 →
Publication:
US 2022/0160833
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,997 →
Publication:
US 2022/0088137
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/543,020 →
Publication:
US 2022/0088138
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Application:
61/831,421 →
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
62/347,075 →
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
62/442,219 →
Methods for the Ex Vivo Induction of Tissue Regeneration in Microbiopsies
Application:
63/136,515 →
Methods and Compositions Used to Modify Chromatin Architecture to Regulate Phenotype in Aging and Cancer
Application:
63/155,628 →
Use of Protocadherins in Methods of Diagnosing and Treating Cancer
Application:
63/155,631 →
Methods for the Temporal Regulation of Reprogramming Factors in Mammalian Cells
Application:
63/256,284 →
Methods for Modulating the Regenerative Phenotype in Mammalian Cells
Application:
63/256,286 →
Use of Protocadherins in Methods of Diagnosing and Treating Cancer
Application:
63/274,731 →
Methods and Compositions Used to Modify Chromatin Architecture to Regulate Phenotype in Aging and Cancer
Application:
63/274,734 →
Methods for the Temporal Regulation of Reprogramming Factors in Mammalian Cells
Application:
63/274,736 →
Improved Methods for Inducing the Maturation of Mammalian Cells
Application:
63/289,411 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 2013
From: WEST, MICHAEL; CHAPMAN, KAREN
To: BIOTIME, INC.
Reel/Frame 030610/0036 →
Assignment of Assignor's Interest
Dec 20, 2016
From: WEST, MICHAEL D.; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 040696/0336 →
Assignment of Assignor's Interest
Sep 1, 2017
From: WEST, MICHAEL D.
To: BIOTIME, INC.
Reel/Frame 043473/0102 →
Assignment of Assignor's Interest
Sep 13, 2017
From: WEST, MICHAEL D.
To: BIOTIME, INC.
Reel/Frame 043579/0743 →
Assignment of Assignor's Interest
Sep 26, 2018
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 046976/0159 →
Assignment of Assignor's Interest
Aug 29, 2019
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 050215/0924 →
Change of Name
Jul 22, 2020
From: BIOTIME INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 053275/0432 →
Assignment of Assignor's Interest
Oct 7, 2020
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 054001/0950 →
Change of Name
Oct 7, 2020
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 054005/0749 →
Assignment of Assignor's Interest
Jun 4, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 056443/0076 →
Assignment of Assignor's Interest
Jun 4, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 056442/0428 →
Assignment of Assignor's Interest
Oct 1, 2021
From: WEST, MICHAEL; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 057668/0341 →
Assignment of Assignor's Interest
Oct 1, 2021
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 057668/0377 →
Assignment of Assignor's Interest
Oct 11, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 057751/0352 →
Assignment of Assignor's Interest
Dec 1, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058254/0344 →
Assignment of Assignor's Interest
Dec 1, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058254/0298 →
Change of Name
Dec 14, 2021
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 058380/0185 →
Assignment of Assignor's Interest
Jan 28, 2022
From: WEST, MICHAEL D.; STERNBERG, HAL
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058816/0925 →
Assignment of Assignor's Interest
Jan 28, 2022
From: WEST, MICHAEL D.; STERNBERG, HAL
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058816/0905 →
Merger and Change of Name
Mar 9, 2022
From: BIOTIME, INC.; LINEAGE CELL THERAPEUTICS, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 059211/0304 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059211/0256 →
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059211/0285 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 059211/0320 →
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059213/0084 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 059213/0272 →